🇰🇷 Palsonify in South Korea

Palsonify (PALTUSOTINE) regulatory status in South Korea.

Marketing authorisations

MFDS

  • Status: likely_approved

MFDS

  • Status: likely_approved

Palsonify in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in South Korea

Frequently asked questions

Is Palsonify approved in South Korea?

Yes. MFDS has authorised it; MFDS has authorised it.

Who is the marketing authorisation holder for Palsonify in South Korea?

Crinetics is the originator. The local marketing authorisation holder may differ — check the official source linked above.